Know Cancer

or
forgot password

A Randomized Prospective Trial Comparing Split Dose Polyethylene Glycol-Based Lavage With Clear Fluids Versus Split Dose Polyethylene Glycol-Based Lavage With a Low-Residue Diet in Preparation of Patients for Colonoscopy.


N/A
18 Years
74 Years
Open (Enrolling)
Both
Colorectal Cancer

Thank you

Trial Information

A Randomized Prospective Trial Comparing Split Dose Polyethylene Glycol-Based Lavage With Clear Fluids Versus Split Dose Polyethylene Glycol-Based Lavage With a Low-Residue Diet in Preparation of Patients for Colonoscopy.


All patients between the ages 18-74 years referred to the Forzani MacPhail Colon Cancer
Screening Centre (CCSC) in Calgary, Alberta, Canada for colonoscopy will be considered for
inclusion. During pre-assessments at the clinic, patients are asked to consider a general
research consent. If they agree to that, then they will be approached for consideration of
participating in this study and presented with an "Invitation to Participate in a Research
Study" form ; the study assistant will obtain final consent if they agree. Those not
interested in participating will simply receive their physician's standard bowel preparation
protocol. There will be no coercion of any sort. Enrollment of participants will be
performed with block randomizations of 2, 4, 6 and 8 by using a computer-generated table,
with allocation concealment maintained through the use of consecutively numbered sealed
envelopes. Colonoscopists and investigators will be blinded to allocation groups. Patients
will be allocated to one of two groups: (1) Split dose Polyethylene Glycol Based Lavage (2L
+ 2L) with Standard dietary instructions- a low fibre diet for 4 days prior to colonoscopy
and clear fluids after a low-fibre breakfast on the day before procedure; (2) Split dose
Polyethylene Glycol Based Lavage (2L + 2L) with Low Fibre Lunch dietary instructions- a low
fibre diet for 4 days prior to colonoscopy and clear fluids after a low-fibre breakfast and
low-fibre lunch on the day before procedure

A study assistant will assign patients to their group based on the Randomization and
instruct them on the proper use of their assigned bowel preparation method. Patients will be
given a tolerability questionnaire, which has been modified from a previously used
questionnaire, to be completed once their bowel preparation is finished and before coming to
the CCSC for the colonoscopy (included in the appendix). Patient concerns or questions
regarding the preparation will be directed toward the study assistant or clinic nurses as
opposed to their endoscopist, so as to avoid un-blinding the Colonoscopist. The physician
performing the procedure will then complete an Ottawa Bowel Preparation Scale, a validated
Simplified Bowel Preparation scale and a New Bowel Prep Scale to assess colon cleanliness.


Inclusion Criteria:



- Patients between 18 to 74 Years referred to the Forzani & MacPhail Colon Cancer
Screening Centre in Calgary, Alberta, Canada for Colonoscopy will be considered for
inclusion.

Exclusion Criteria:

- Patients with acute Coronary Syndrome,

- Congestive Heart Failure,

- Unstable Angina,

- Known or suspected Renal Failure,

- Ascites,

- Known or suspected Bowel obstruction or

- Other comorbidities that may prevent Colonoscopy will be excluded.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)

Outcome Measure:

Quality of Bowel Cleanliness

Outcome Description:

Ottawa bowel prep scale will be done by the Doctor to assess the quality of bowel cleanliness. The right, mid and rectosigmoid colon are each rated on a 5-point scale (0-4). Also a complete 3 point rating for overall colonic fluid is assessed giving an overall score range of 0-14. An excellent preperation should score 0-1, a good preparation 2-4, while scores >4 would indicate progressively worsening bowel preparations. A Simplified overall cleanliness score and a New bowel prep score will be completed and compared to the Ottawa scale.

Outcome Time Frame:

Procedure is completed (1 hour time). Questionnaires are manually entered by an assistant into the study database on the same day of collection.

Safety Issue:

No

Principal Investigator

Alaa Rostom, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Calgary

Authority:

Canada: Ethics Review Committee

Study ID:

24206

NCT ID:

NCT01610895

Start Date:

December 2011

Completion Date:

October 2012

Related Keywords:

  • Colorectal Cancer
  • Colonoscopy
  • low fibre diet
  • clear fluids
  • Bowel Preparation
  • Colorectal Neoplasms

Name

Location